Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mucolytic activity refers to the ability of agents to break down or reduce the viscosity of mucus in the respiratory tract, facilitating easier clearance. This effect is achieved through various mechanisms, including breaking disulfide bonds within mucin glycoproteins or degrading extracellular DNA, ultimately leading to improved airway function and reduced infection risk in conditions like COPD, cystic fibrosis, and bronchiectasis.
Breaking disulfide bonds in mucins, degrading extracellular DNA, modulating secretion/metabolism of mucus components.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mucolytic Activity.